Abstract 1555
To assess the effects of early postnatal D therapy on the blood cell count, we have reviewed 179 preterm infants (<2000gm) who were participated in a double-blind control trial of early D therapy for the prevention of chronic lung disease (86 received saline placebo and 93 received D). D was given iv q.12.h. in tapering doses: 0.25 mg/kg on day 1 to 7; 0.12 mg/kg on day 8 to 14; 0.05 mg/kg on day 15 to 21; 0.02 mg/kg on day 21 to 28. Blood samples for hematological data were obtained on day 0, 3, 7, 10, 14, 21 and 28. None of these infants received prenatal steroid. The mean±SD B.W. and gest. age for the control and D groups were 1.3±0.4 vs. 1.3±0.3 kg; and 28.9±2.7 vs. 29.2±3.1 wks respectively. The age of the first dose of D given was 7.6±4.8 hrs.
Multiple regression using general estimating equations revealed significant (p<0.01) difference in the overall response curve of the total WBC, neutrophil, lymphocyte and eosinophil counts between the groups, indicating a treatment effect. The WBC count was sign. higher in the D group from days 7 through 14, with much of the increases attributed to an increase in segmented neutrophils and band forms. A subsequent decrease of lymphocyte count was noted and persisted up to 28 day in D group. The hematocrit and platelet counts were slightly higher in D group than the control but the difference was not statistically significant. The low platelet count that often seen in control infants with bacteremia was not noted in the D group. We concluded that the potential alternations in hematological values should be taken into consideration when evaluating infants with D therapy.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peng, CT., Lin, HC., Lin, YJ. et al. The Effects of Early Postnatal Dexamethasone (D) Therapy on the Blood Cell Count in Preterm Infants. Pediatr Res 45, 264 (1999). https://doi.org/10.1203/00006450-199904020-01572
Issue Date:
DOI: https://doi.org/10.1203/00006450-199904020-01572